|
Volumn 62, Issue 11, 1996, Pages 1697-
|
The tricontinental mycophenolate mofetil trial [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
CLINICAL TRIAL;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
KIDNEY TRANSPLANTATION;
LETTER;
MULTICENTER STUDY;
PRIORITY JOURNAL;
CLINICAL TRIALS;
CYCLOSPORINE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
|
EID: 0030473520
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-199612150-00033 Document Type: Letter |
Times cited : (9)
|
References (2)
|